[1]Yoshida EM. The Crohn's Disease Activity Index, its derivatives and the Inflammatory Bowel Disease Questionnaire: a review of instruments to assess Crohn's disease[J]. Can J Gastroenterol, 1999,13(1):65-73.
[2]Vadstrup K, Galsgaard ED, Gerwien J, et al. Validation and Optimization of an Ex Vivo Assay of Intestinal Mucosal Biopsies in Crohn's Disease: Reflects Inflammation and Drug Effects [J]. Plos One, 2016, 11(5):e0155335.
[3]Zhao Y, Huang ZJ, Rahman M, et al. Radicicol, an Hsp90 inhibitor, inhibits intestinal inflammation and leakage in aIBDominal sepsis[J]. J Surg Res, 2013, 182(2):312-319.
[4]夏蜀娴. 热休克转录因子2和促炎症细胞因子在溃疡性结肠炎中的表达研究[D]. 昆明医科大学, 2014.
[5]Liang D, Li F, Fu Y, et al. Thymol Inhibits LPS-Stimulated Inflammatory Response via Down-Regulation of NF-κB and MAPK Signaling Pathways in Mouse Mammary Epithelial Cells[J]. Inflammation, 2014, 37(1):214-220.
[6]Yang Y, Wang J, Yang Q, et al. Shikonin inhibits the lipopolysaccharide-induced release of HMGB1 in RAW264.7 cells via IFN and NF-κB signaling pathways[J]. Int Immunopharmacol, 2014, 19(1):81-87.
[7]Cominelli F, Arseneau KO, Rodriguez-Palacios A, et al. Uncovering Pathogenic Mechanisms of Inflammatory Bowel Disease Using Mouse Models of Crohn's Disease-Like Ileitis: What is the Right Model [J]? Cell Mol Gastroenterol Hepatol, 2017, 4(1):19-25.
[8]Dunn ET, Taylor ES, Stebbings S, et al. Distinct immune signatures in the colon of Crohn's disease and ankylosing spondylitis patients in the absence of inflammation[J]. Immunol Cell Biol, 2016, 94(5):421-426.
[9]Zhang Y, Li E, Gathungu G, et al. Sa2003 Influence of Crohn's Disease-Related Genetic Defects in Innate Immune Function on Ileal- Associated Microbiome[J]. Gastroenterology, 2016, 150(4):S429-S429.
[10]Antón M, Alén F, Gómez d HR, et al. Oleoylethanolamide prevents neuroimmune HMGB1/TLR4/NF-kB danger signaling in rat frontal cortex and depressive-like behavior induced by ethanol binge administration [J]. Addict Biol, 2017, 22(3):724-741.
[11]Van d BF, Kruithof E, De VM, et al. Crohn's disease associated with spondyloarthropathy: effect of TNF-alpha blockade with infliximab on articular symptoms[J]. Lancet, 2000, 356(9244):1821-1822.
[12]马丹. 结肠化生Paneth细胞通过TLR4通路调节IL23/Th17轴在炎症性肠病发病机制中的作用研究[D]. 第二军医大学, 2016.
[13]蔺晓源, 刘杰民. TLR4/MyD88/NF-κB信号通路与溃疡性结肠炎[J]. 胃肠病学, 2013, 18(4):244-246.
[14]陈晓, 王启之, 梁冰,等. Toll样受体4、Myd88在溃疡性结肠炎结肠组织中的表达及相关性研究[J]. 中华消化杂志, 2011, 31(10):699-700.
[15]苗新普, 欧阳钦, 韦红. COX-2、PPARγ和NF-κB p65在溃疡性结肠炎组织中的表达及意义[J]. 世界华人消化杂志, 2010,18(25):2660-2665.
[16]Wang J, Wang H, Shi J, et al. Effects of bone marrow MSCs transfected with sRAGE on the intervention of HMGB1 induced immuno-inflammatory reaction[J]. Int J Clin Exp Pathol, 2015, 8(10):12028-12035.
[17]Palone F, Vitali R, Cucchiara S, et al. Fecal HMGB1 Reveals Microscopic Inflammation in Adult and Pediatric Patients with Inflammatory Bowel Disease in Clinical and Endoscopic Remission[J]. Inflamm Bowel Dis, 2016, 48(12):2886-2893.
[18]Zhou L, Niu J, Xia TM, et al. Heat shock factor 2 inhibits LPS-stimulated inflammation in Caco-2 cell via MAPKs and NF-κB pathways[J]. Medical J West China, 2017, 56(3):85-90. |